市場調査レポート
商品コード
1208639
ワクチン用アイソサーマルボックスの世界市場-2022-2029Global Isothermal Boxes For Vaccine Market - 2022-2029 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ワクチン用アイソサーマルボックスの世界市場-2022-2029 |
出版日: 2023年02月01日
発行: DataM Intelligence
ページ情報: 英文 214 Pages
納期: 約2営業日
|
ワクチン用等温ボックスの世界市場規模は、予測期間(2022-2029年)内にCAGR7.0%で成長すると予測されています。
予防接種は、保冷ボックスや小型抗体輸送機を使って出荷時に保冷されます。等温ボックスは、コールドボックスと予防接種用キャリアーのスーパーセットです。予防接種用トランスポーターは、体積が小さいことを除けば、コールドボックスと同様の特性を備えています。
ワクチン用等温箱市場は、材料に基づいて、ポリウレタン、ポリプロピレン、ポリエチレン、ポリスチレン、その他に分類することができます。様々な用途がある素材タイプはポリウレタンです。ポリオールとジイソシアネートを反応させて、ポリウレタンフォームを製造します。高密度ポリウレタンフォームにアルミナ層を2層成形し、十分な力で結合させることで優れた硬度を実現したものが等温充填材です。
また、ワクチン分野では、ロングレンジとショートレンジの等温ボックスがあります。長距離用等温ワクチン容器のサイズは、5~15リットルと15~25リットルの2種類です。ワクチン分野におけるショートレンジの等温ボックスは、15リットルと25リットル、5リットルと15リットル、5リットル未満に分けられます。
ワクチンのラストワンマイル到達のための経済的なコールドチェーンソリューションに対する需要の向上が、恒温ボックスを後押ししています。
ワクチンのラストワンマイル搬送を可能にする経済的なコールドチェーンソリューションに対する需要の高まりが、恒温式容器を後押ししています。
ワクチンは、世界の健康と開発における最も重要な成功の一つです。ワクチンは、2世紀以上にわたってポリオ、はしか、天然痘などの病気の惨禍を減少させ、子どもたちが健康で幸せに成長できるようにすることに成功してきました。ユニセフによると、COVID-19が到着する以前から、毎分5人以上の命を救い、年間300万人もの死亡を回避しています。
世界の予防接種の取り組みにより、子どもたちは歩き、遊び、学ぶことができます。ワクチンを接種した子どもたちは学校での成績が良くなり、その結果、地域社会に経済的な利益をもたらしています。ワクチンは現在、世界の福祉を向上させる最も費用対効果の高い方法の1つと考えられています。
しかし、ラスト・マイル・リーチへの不適切かつ無能なワクチン供給は、公衆衛生に対する最大の脅威の一つです。ユニセフによると、毎年約2,000万人の子どもたちが命を救うためのワクチンを手に入れることができません。多くの場合、ワクチンを必要とする最も貧しく周縁化された子どもたちが、ワクチンを入手する可能性が最も低いのです。そこでユニセフとそのパートナーは、太陽光発電、モバイルテクノロジー、テレメトリックスを活用し、極端な暑さや寒さのためにワクチンの効果が失われることなく、すべての子どもたちにワクチンが行き渡るよう取り組んでいます。
ウェルビーイングのスペシャリストが一人でワクチンの入った等温ボックス、特に抗体トランスポーターは小さいので、車両や徒歩で努力会場に運ぶことができます。さらに、等温抗体は、必須医療生息地から過渡的な予防接種の店舗に予防接種を移動させることもできます。
在庫網の管理不良がワクチン用アイソサーマルボックス市場を抑制している
世界のワクチン用等温ボックス市場は、貧弱なサプライチェーン管理によって阻害されると予測されます。冷却剤パックの不適切な使用や不適切な恒温ボックスの選択などは、管理不良の一例です。数々の困難がコールドチェーン物流管理を妨げているのです。
大きな需要があるにもかかわらず、等温ワクチン接種など規制の厳しい医薬品の配送の難しさに対応できる物流事業者はごくわずかです。例えば米国では、冷蔵倉庫の78%が20年以上前のもので、現代の運用ニーズにはそぐわないものです。
車両管理の非効率性も、解決しなければならない問題の一つです。冷蔵庫や車両は頻繁に故障します。余分な部品を注文し、定期的なメンテナンスを行うことは、オペレーションを遅らせる可能性があります。同時に、コールドチェーンが車両の動きを把握できていないため、出荷が遅れたり、輸入品が入港地で長期間待たされたりすることもあります。
さらに、正確な温度・湿度条件を必要とする原料の輸送はコストがかかります。しかし、限られた視界と管理のもとでは、わずかな輸送環境の変化でも大きな損失につながる可能性があります。特に高価な医薬品となると、そのリスクは大きくなります。
特に高価な医薬品は、サプライチェーンが適切な温度範囲に保たれていなければ、予防接種の効果も損なわれてしまう可能性があります。現在、凍結防止のための等温包装の実用化に向けた取り組みが進められています。
COVID-19の影響分析
COVID-19の大流行がもたらした世界の健康危機は、SARS-CoV-2ウイルスに対抗するための等温ワクチン輸送ボックスの需要を押し上げました。熱に弱いワクチンはすべて、アクティブまたはパッシブな低温製造法を用いて保管温度範囲が制御されていますが、初期のCOVID-19ワクチンは、-90~-60℃の間で保管・輸送する必要があります。
従来の-25/-15°C範囲の共晶板は、-70°C付近に融点がないため、この温度要件を満たすことができません。78.5℃での昇華エンタルピーが573 kJ.kg-1(25,2 kJ.mol-1)であることから、これらの予防接種を保冷するためには、ドライアイスが最適なアプローチであると言えます。
予防接種など熱に弱い健康食品を輸送する際、外部との熱交換を補うために保冷剤を入れた断熱ボックスが提供されています。
市場を牽引するのは、高品質のCOVID-19ワクチンを世界規模で輸送するために、温度制御された保冷シッパーが必要とされることだと思われます。例えば、Pfizerのjabは-70℃での長期保管が必要ですが、Modernaのjabは-20℃での長期保管が必要です。
COVID-19の予防接種は、COVID-19のパンデミックを食い止めるのに役立つ重要な予防措置です。予防接種キャンペーンの普及とワクチン製造の効率化に伴い、等温ボックスのニーズが高まることが予想されます。業界の参入企業は、世界の等温ワクチンボックス市場でその地位を強化しています。
The global isothermal boxes for vaccine market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 7.0% within the forecast period (2022-2029).
Immunizations are kept chilled during shipment using cold boxes and miniature antibody transporters. Isothermal boxes are the superset of cold boxes and vaccination carriers. Immunization transporters offer similar properties as cold boxes, except they have a smaller volume.
Based on the material, isothermal boxes for the vaccine market can be classified as polyurethane, polypropylene, polyethylene, polystyrene and others. A material type that has many different applications is polyurethane. Polyols and diisocyanates react to produce polyurethane foam. High-density polyurethane foam with two aluminized layers molded and linked with enough force to provide outstanding hardness makes up isothermal packing.
For the vaccination sector, there are also long-range and short-range isothermal boxes. The two sizes of long-range isothermal vaccine containers are 5-15 liters and 15-25 liters. Short-range isothermal boxes in the vaccine sector are divided into 15 and 25 liters, 5 and 15 liters and under 5 liters.
Improving demand for economical cold chain solutions for the last-mile reach of vaccines is boosting the isothermal boxes.
Improving demand for economical cold chain solutions for the last-mile reach of vaccines is boosting the isothermal boxes
Vaccines are one of the most significant successes in world health and development. Vaccines have successfully decreased the scourge of diseases like polio, measles and smallpox for over two centuries, allowing children to grow healthy and happy. According to UNICEF, even before COVID-19 arrived, they saved more than five lives every minute, averting up to three million fatalities yearly.
Children can walk, play and learn thanks to global immunization initiatives. Vaccinated children perform better in school, resulting in economic benefits for their communities. Vaccines are now considered one of the most cost-effective ways to improve global welfare.
However, improper and incompetent vaccine supply for the last-mile reach is one of the top threats to public health. According to UNICEF, some 20 million children miss out on life-saving vaccines annually. The poorest and most marginalized children who often need vaccines are the least likely to get them. Therefore, UNICEF and their partners harness solar power, mobile technology and telemetrics to assure vaccines reach all children without losing their effectiveness from vulnerability to extreme heat or cold weather conditions.
A solitary well-being specialist can convey isothermal boxes for the vaccine, particularly antibody transporters, via vehicle or walking to an effort meeting because of their small size. Moreover, isothermal antibodies also move immunizations from essential medical care habitats to transitional immunization stores.
Poor administration of the inventory network is restraining the isothermal boxes for the vaccine market
The global isothermal boxes for vaccines market is projected to be hampered by poor supply chain management. The improper use of coolant packs and the selection of inappropriate isothermal boxes, among other things, are examples of poor management. A slew of difficulties is hampering cold chain logistics management.
Despite the great demand, only a few logistics businesses can meet the difficulty of delivering isothermal vaccination and other highly regulated pharmaceutical products. In U.S., for example, 78 percent of cold storage warehouses are over two decades old and unfit for modern operational needs.
Inefficiencies in fleet management are another issue that must be addressed. Refrigerators and vehicles frequently fail. Ordering extra parts and performing routine maintenance might slow down operations. At the same time, a lack of cold chain insight into fleet movements can cause shipping delays and instances where imported products wait at ports of entry for an extended period.
Furthermore, transporting materials that require exact temperature and humidity conditions is costly. However, with limited sight and control, even little changes in the transportation environment might result in significant losses. The stakes are particularly higher when it comes to high-value pharmaceuticals.
As a result, vaccinations will likely lose efficacy if the supply chain is not kept within the proper temperature range. Significant efforts are being made to bring freeze-safe isothermal vaccination packaging to market.
COVID-19 Impact Analysis
The worldwide health crisis brought on by the COVID-19 pandemic has boosted demand for isothermal vaccine transport boxes to combat the SARS-CoV-2 virus. All heat-sensitive vaccines have storage temperature ranges controlled using active or passive cold manufacturing methods, but the earliest COVID-19 vaccines must be stored and transported between -90 and -60 °C.
Traditional eutectic plates for the -25/-15 °C range cannot meet the temperature requirement since they do not have melting temperatures near -70 °C. With a sublimation enthalpy of 573 kJ.kg-1 (25,2 kJ.mol-1) at -78.5 °C, dry ice is the best approach to keep these vaccinations cold.
Insulated boxes are supplied with a cold source to compensate for thermal exchanges with the outside when transporting vaccinations and other heat-sensitive health items.
The market is likely driven by the requirement for temperature-controlled thermal shippers to transfer high-quality COVID-19 vaccines globally. For example, the Pfizer jab requires long-term storage at -70°C, but the Moderna jab requires long-term storage at -20°C.
COVID-19 immunization is an important preventative step that can assist in bringing the COVID-19 pandemic to a stop. The need for isothermal boxes is predicted to rise as vaccination campaigns become widespread and vaccine manufacturing becomes more efficient. The industry's participants are strengthening their position in the worldwide isothermal vaccine boxes market.
The global isothermal boxes for vaccine market is segmented by product, material and region.
Long range vaccine boxes are portable with reduced capacity for a longer travel time range of 24 hours to 8 days
Based on product, the global isothermal boxes for vaccine market is segmented into short range and long range. The long range holds a major share in isothermal boxes for the vaccine market. Vaccines are kept chilled throughout shipment using cold boxes and miniature vaccine carriers. Isothermal boxes are defined as the superset of cold boxes and vaccine carriers. Vaccine carriers are similar to cold boxes, except that they have a lower volume. Because both cold boxes and vaccine carriers are passive carriers, coolant packs that offer warmth for a set amount of time are required.
Vaccine carriers are portable due to their reduced capacity. They're used to deliver vaccinations and diluents from hospitals to rural locations where ice and refrigeration aren't available.
Depending on their use, cold boxes can last from a few hours to many days. Vaccines are not time-limited, but they must be kept between 2 and 8 degrees Celsius from the time they are created until they are administered.
In comparison to any other type of vaccine packaging, the isothermal container constructed of expanded polyethylene and polypropylene is in high demand. It provides good thermal insulation. Vacuum Insulation Panels, dry ice or PCM-filled cooling plates can keep the temperature steady for hours or days.
Asia-Pacific market is expected to expand at a higher rate than the rest of the regions due to the increasing number of small and unorganized packaging manufacturers in emerging countries such as China, India, Indonesia and others
The Asia-Pacific market is expected to expand at a higher rate than the rest of the regions due to the increasing number of small and unorganized packaging manufacturers in emerging countries such as China, India, Indonesia and others.
Furthermore, due to rising vaccination awareness and increased immunization programs, Asia-Pacific presents lucrative prospects for isothermal boxes key vaccine industry players to grow in the forecast period. The market expansion in this region may be attributed to an increase in vaccination demand, senior population, awareness and continued government support for vaccine development.
All countries and territories in Asia-Pacific have established vaccination programs that include a minimum number of routine vaccines (such as those for polio, diphtheria, tetanus, pertussis and measles); additional vaccines (such as those for pneumococcus, rotavirus and human papillomavirus) are added at the national or subnational level based on local morbidity, mortality and cost-effectiveness analysis.
In addition, In 2019, the overall vaccination of children against pertussis (provided through combined vaccines containing diphtheria and tetanus), measles and hepatitis B was high in most Asia-Pacific countries. While vaccination rates have plateaued at a high level in many countries and territories in Asia-Pacific, some countries with historically low rates have made substantial progress in recent years.
Vaccine safety surveillance is improving globally, with 73% and 63% of nations reporting adverse events following immunization in the WHO areas of South East Asia and the Western Pacific, respectively. Thus improving vaccination percentage in the region has created a huge market share for isothermal boxes for vaccine storage in the Asia-Pacific region.
The global isothermal boxes for vaccine market is highly competitive with local and global key players. The key players contributing to the market's growth are B Medical Systems, BLOWKINGS India, Sonoco ThermoSafe, Termo-Kont MK LLC, AOV International LLP, Apex International, PHC Holdings Corporation, Tempack, Tecnisample SL, Nilkamal Material Handling, Isonova among others.
The major companies are adopting several growth strategies, such as product launches, acquisitions and collaborations, contributing to the global growth of the isothermal boxes for vaccine market.
B Medical Systems
Overview: B Medical Systems manufactures and distributes innovative solutions required to transport and store blood components, vaccines, laboratory specimens, etc. The company offers an end-to-end solution of refrigerated devices certified by the US FDA, EU MDR and WHO PQS. The company's portfolio includes laboratory refrigerators, medical-grade vaccine refrigerators, laboratory freezers, blood bank refrigerators, plasma freezers, contact shock freezers, ultra-low freezers and transport boxes. B Medical Systems offer storage and transportation products ranging from -80 °C to +4°C, which the Govt of Luxembourg is currently using for transporting COVID-19 vaccines.
The global isothermal boxes for vaccine market report would provide approximately 69 market data tables,70 figures and 214 pages.
Target Audience 2022
LIST NOT EXHAUSTIVE